DoH Policies screened during the period: 1 October 2022- 31 December 2022
Date published: 23 May 2023
In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact.
NICE Technology Appraisal TA824 - Dexamethasone intravitreal implant for treating diabetic macular oedema (partial review of TA349) (PDF 513KB)